A comparison of the antiproliferative properties of recombinant human IFN-α2 and IFN-ω in human bone marrow culture

Journal of Interferon and Cytokine Research

Volumn 17, Issue 6, 1997, Pages 327-329

  Tiefenthaler, M ^a   Geisen, F ^a   Schirmer, M ^a   Konwalinka, G ^a  

^a Clinic of Internal Medicine   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2 INTERFERON; RECOMBINANT INTERFERON; RECOMBINANT OMEGA INTERFERON; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030925310     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.327     Document Type: Article

References (13)

1. BENOIT, P., MAGUIRE, D., PLAVEC, I., KOCHER, H., TOVEY, M., and MEYER, F. (1993). A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor. J. Immunol. 150, 707-716.
2. ADOLF, G.R., MAURER FOGY, I., KALSNER, I., and CANTELL, K. (1990). Purification and characterization of natural human interferon omega 1. Two alternative cleavage sites for the signal peptidase. J. Biol. Chem. 265, 9290-9295.
3. ADOLF, G.R. (1987). Antigenic structure of human interferon omega 1 (interferon alpha II1): comparison with other human interferons. J. Gen. Virol. 68, 1669-1676.
4. BÖYUM, T. (1974). Separation of blood leukocytes, granulocytes and lymphocytes. Tissue Antigen 4, 269.
5. ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID LEUKEMIA. (1993). Treatment of Ph-positive chronic myeloid leukemia with alpha-interferon (ROFERON-A). The Italian Cooperative Study Group experience. Leuk. Lymphoma. 11(Suppl. 1), 153-157.
6. + chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients. Haematologica 77, 204-214.
7. BEELEN, D.W., GRAEVEN, U., ELMAAGACLI, A.H., NIEDERLE, N., KLOKE, O., OPALKA, B., and SCHAEFER, U.W. (1995). Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome. Blood 85, 2981-2990.
8. BRAND, C.M., and LEADBEATER, L. (1994). Specificities of therapy-induced anti-interferon-alpha antibodies. J. Interferon Res. 14, 201-203.
9. PRUMMER, O., STREICHAN, U., HEIMPEL, H., and PORZSOLT, F. (1994). Sensitive antiproliferative neutralization assay for the detection of neutralizing IFN-alpha and IFN-beta antibodies. J. Immunol. Methods 171, 45-53.
10. WUSSOW, P.V., JAKSCHIES, D., FREUND, M., HEHLMANN, R., BROCKHAUS, F., HOCHKEPPEL, H., HORISBERGER, M., and DEICHER, H. (1991). Treatment of anti-recombinant interferon-alpha 2 antibody positive CML patients with natural interferon-alpha. Br. J. Haematol. 78, 210-216.
11. PRUMMER, O., BUNJES, D., WIESNETH, M., ARNOLD, R., PORZSOLT, F., and HEIMPEL, H. (1994). High-titre interferon-alpha antibodies in a patient with chronic graft-versus-host disease after allogenic bone marrow transplantation. Bone Marrow Transplant. 14, 483-486.
12. DOWDING, C., GORDON, M., GUO, A.P., MAISON, D., OSTERHOLZ, J., SICZKOWSKI, M., and GOLDMAN, J. (1993). Potential mechanisms of action of interferon-alpha in CML. Leuk. Lymphoma. 11(Suppl. 1), 185-191.
13. DUNBAR, C.F., and STEWART, F.M. (1992). Separating the wheat from the chaff: selection of benign hematopoietic cells in chronic myeloid leukemia. Blood 79, 1107-1109.